4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-003286
CHIEF COMMERCIAL OFFICER gave up 1,240 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 2,270 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-03-21 | Option exercise | +2,270 | 8,612 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-03-21 | Shares withheld for taxes | −1,240 | $10.98 | $13,615 | 7,372 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-03-21 | Option exercise · Restricted Share Unit | −2,270 | 0 | D | ||
Loading xslF345X03/form4-03232022_040326.xml…